Cardura Tablet
Product Images NDC 58151-075
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardura (NDC 58151-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 3. (Image 02)
This data provides a summary of results from placebo-controlled trials evaluating the effectiveness of CARDURA in treating benign prostatic hyperplasia (BPH). The trials assessed parameters such as maximum flow rate and symptom scores in patients receiving different doses of CARDURA compared to those receiving a placebo. Results show improvements in symptom scores and flow rates with increasing doses of CARDURA over placebo. The data also includes information on the duration of the studies and the number of participants in each group.*
Figure 1 – Study 1 (Image 03)
This text provides information about the mean change in total symptom score and mean increase in maximum urinary flow rate from baseline in a study comparing the effects of a placebo and doxazosin titration over a duration of weeks. Results show statistically significant changes compared to placebo and baseline. Doxazosin was titrated to a maximum of 8 mg.*
Cardura (doxazosin) Tablets 1 mg Bottle Label (Image 04)
This text provides information about a medication called "Taxura" (doxazosin) in the form of tablets with a strength of 1 mg. The tablets are in a pack of 100 and are for prescription use only. It also mentions the recommended storage condition of 25°C. The product is associated with the company "Viatris". The text includes the NDC code, GTIN, and LOT/EXP numbers for identification and tracking purposes.*
Cardura (doxazosin) Tablets 2 mg Bottle Label (Image 05)
Cardura (doxazosin) Tablets 4 mg Bottle Label (Image 06)
This text mentions information about storing Cardura (doxazosin) tablets at 25°C and provides details such as NDC code, quantity (100 tablets), and the manufacturer (Viatris Specialty LLC). The prescription drug is indicated for the treatment of high blood pressure and benign prostatic hyperplasia.*
Cardura (doxazosin) Tablets 8 mg Bottle Label (Image 07)
This is a prescription medicine called Cardura (doxazosin) in tablet form with a strength of 8 mg. The recommended dosage is unspecified in the text, but it is advised to consult a healthcare provider for the appropriate dose. The medication comes in a container with 100 tablets and is available via prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.